Curiva is commercializing a non-invasive wearable diagnostics patch for gynecologic malignancy detection - diaPatchTM. Curiva’s flagship product allows doctors, healthcare professionals and patients to accurately test for high-risk biomarkers that forecast the onset of cervical cancer.